Philipp is an antimicrobial development specialist and serves as CSO to discoveric bio beta.
In his previous career he held different positions in anti-infective biotech companies, including Evlova SA, Polyphor Ltd., Selmod GmbH, and Allecra Therapeutics SAS. In these positions Philipp lead projects from early stage discovery to late stage clinical development, covering screening, hit-to-lead, pre-clinical and clinical microbiology and PK-PD.
Philipp is a microbiologist by training and holds a PhD from the Biozentrum, University of Basel, and a PostDoc from the Institut Pasteur, Paris.
